*JOIN THE PHYSIONIC INSIDERS [PREMIUM CONTENT]*Join the Physionic Insiders: https://bit.ly/PhysionicInsiders2 *HEALTH AUTONOMY [COURSE]*Learn to Analyze & Apply Studies for Yourself: https://bit.ly/healthautonomy*JOIN THE COMMUNITY*Join my Community [It’s Free!]: https://bit.ly/PhysionicCommunity2*EMAIL LIST*1-2 Weekly Email of Value [It’s Free!]: http://bit.ly/2AXIzK6*HIRE ME FOR CONSULTING:* Consulting: https://bit.ly/3dmUl2H Created with BiorenderAnti-Aging Series: https://www.youtube.com/playlist?list=PLwiri7XRU2i-HLExt7W-5qp_z2tIP_UvU0:00 - Introduction0:55 - Senolytics: An Advanced Future3:44 - Bone, Kidneys, Liver, and…5:57 - Molecules and ConsiderationsReferences [Funding/Conflicts are provided in the free article (found in the email list and Physionic Community Article Library)][Study 1093] Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019;47:446–456. doi:10.1016/j.ebiom.2019.08.069.[Study 1094] Farr JN, Atkinson EJ, Achenbach SJ, et al. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nat Med. 2024;30:2605–2612. doi:10.1038/s41591-024-03096-2.[Study 1095] Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine. 2019;40:554–563. doi:10.1016/j.ebiom.2018.12.052.[Study 1096] Martyanov V, Whitfield ML, Varga J. Senescence signature in skin biopsies from systemic sclerosis patients treated with senolytic therapy: potential predictor of clinical response? Arthritis Rheumatol. 2019;71(10):1766–1767. doi:10.1002/art.40934.[Study 1097] Hambright WS, Duke VR, Goff AD, et al. Clinical validation of C12FDG as a marker associated with senescence and osteoarthritic phenotypes. Aging Cell. 2024;23. doi:10.1111/acel.14113.[Study 1098] Gao X, Roder J, Minas LT, et al. Effects of two fisetin dosing regimens on reducing senescence-related genes in peripheral blood mononuclear cells in aged humans. Preprints. Published online July 22, 2026. doi:10.20944/preprints202607.1685.v1.[Study 1099] Koning M, Kovynev A, Fondevila MF, et al. Senolytics dasatinib and quercetin in metabolic dysfunction-associated steatohepatitis: a proof-of-principle randomized, controlled trial. Nat Metab. 2026. doi:10.1038/s42255-026-01643-4.Please use the following link to submit your critique: https://bit.ly/PhysionicCritiqueDisclaimer: None of the information provided by this brand is a replacement for your physician's advice. This brand is information for the sake of knowledge and the options of choice it provides, not in any way a personalized prescription. Please consult your physician before making any health related changes.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Physionic
FDA approved Arthritis Drug shown to Stop Aggressive Cancer!
‘An Incredibly Common Food That Melts Clogged Arteries (Most Eat Them Wrong)’
Put these in your Ears and Protect your Brain!
Dr. Rhonda Patrick: ‘Scientists discovered a Supplement that Repairs Aging Mitochondria!’
Get summaries like this every morning.
Free AI-powered recaps of Physionic and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.